EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer
  • Kim, Hwa-Ryeon
  • Yim, Juhye
  • Yoo, Hye-Been
  • Lee, Seung Eon
  • Oh, Sumin
  • ... Yoo, Kyung Hyun
  • 외 7명
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Cancer cells utilize epigenetic alterations to acquire autonomous capabilities for tumor maintenance. Here, we show that pancreatic ductal adenocarcinoma (PDA) cells utilize super-enhancers (SEs) to activate the transcription factor EVI1 (ecotropic viral integration site 1) gene, resulting in activation of an EVI1-dependent transcription program conferring PDA tumorigenesis. Our data indicate that SE is the vital cis-acting element to maintain aberrant EVI1 transcription in PDA cells. Consistent with disease progression and inferior survival outcomes of PDA patients, we further show that EVI1 upregulation is a major cause of aggressive tumor phenotypes. Specifically, EVI1 promotes anchorage-independent growth and motility in vitro and enhances tumor propagation in vivo. Mechanistically, EVI1-dependent activation of tumor-promoting gene expression programs through the stepwise configuration of the active enhancer chromatin attributes to these phenotypes. In sum, our findings support the premise that EVI1 is a crucial driver of oncogenic transcription programs in PDA cells. Further, we emphasize the instructive role of epigenetic aberrancy in establishing PDA tumorigenesis.

제목
EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer
저자
Kim, Hwa-RyeonYim, JuhyeYoo, Hye-BeenLee, Seung EonOh, SuminJung, SungjuHwang, Chang-ilShin, Dong-MyungKim, TaeSooYoo, Kyung HyunKim, You-SunLee, Han-WoongRoe, Jae-Seok
DOI
10.1093/narcan/zcab023
발행일
2021-06
저널명
NAR Cancer
3
2
페이지
1 ~ 15